Follow
Fatima Cardoso
Fatima Cardoso
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal
Verified email at fundacaochampalimaud.pt
Title
Cited by
Cited by
Year
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
36492013
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...
Journal of the National Cancer Institute 98 (4), 262-272, 2006
21662006
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
19292015
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of oncology 26, v8-v30, 2015
17302015
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
15242016
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
14442006
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of oncology 30 (8), 1194-1220, 2019
13942019
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E De Azambuja, F Cardoso, G de Castro, M Colozza, MS Mano, ...
British journal of cancer 96 (10), 1504-1513, 2007
11422007
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
J Cortes, J O'Shaughnessy, D Loesch, JL Blum, LT Vahdat, K Petrakova, ...
The Lancet 377 (9769), 914-923, 2011
11252011
Pembrolizumab for early triple-negative breast cancer
P Schmid, J Cortes, L Pusztai, H McArthur, S Kümmel, J Bergh, C Denkert, ...
New England Journal of Medicine 382 (9), 810-821, 2020
10812020
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
10632007
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
10172018
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
10052017
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017
7912017
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ...
The Breast 23 (5), 489-502, 2014
7762014
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Senkus, S Kyriakides, F Penault-Llorca, P Poortmans, A Thompson, ...
Annals of oncology 24, vi7-vi23, 2013
6782013
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F Cardoso, N Harbeck, L Fallowfield, S Kyriakides, E Senkus
Annals of oncology 23, vii11-vii19, 2012
5782012
Breast cancer (Primer) Nat
N Harbeck, F Penault-Llorca, J Cortes, M Gnant, N Houssami, ...
Rev. Dis. Primers 66, 2019
5682019
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F Cardoso, S Paluch-Shimon, E Senkus, G Curigliano, MS Aapro, F André, ...
Annals of Oncology 31 (12), 1623-1649, 2020
5642020
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer
S Chan, ME Scheulen, S Johnston, K Mross, F Cardoso, C Dittrich, ...
Journal of Clinical Oncology 23 (23), 5314-5322, 2005
5572005
The system can't perform the operation now. Try again later.
Articles 1–20